Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mun Sung Cho"'
Autor:
Hyun Jin Oh, Mun Sung Cho, Jae Wook Lee, Pil-Sang Jang, Nack-Gyun Chung, Bin Cho, Hack-Ki Kim
Publikováno v:
Korean Journal of Pediatrics, Vol 56, Iss 8, Pp 343-350 (2013)
PurposeDespite the established role of imatinib (IM) in chronic myelogenous leukemia (CML) in adults, there are few reports on its efficacy in children. In this study, we compared the outcomes of children with CML before and after the advent of IM-ba
Externí odkaz:
https://doaj.org/article/387f46c492fc423fb172e816fa44ff7e
Autor:
Nack-Gyun Chung, Mun Sung Cho, Pil-Sang Jang, Hyun Jin Oh, Bin Cho, Hack-Ki Kim, Jae Wook Lee
Publikováno v:
Korean Journal of Pediatrics
Korean Journal of Pediatrics, Vol 56, Iss 8, Pp 343-350 (2013)
Korean Journal of Pediatrics, Vol 56, Iss 8, Pp 343-350 (2013)
Purpose: Despite the established role of imatinib (IM) in chronic myelogenous leukemia (CML) in adults, there are few reports on its efficacy in children. In this study, we compared the outcomes of children with CML before and after the advent of IM-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b61bbd4e7574184b4df15d65b9afbee
https://doi.org/10.3345/kjp.2013.56.8.343
https://doi.org/10.3345/kjp.2013.56.8.343
Autor:
Min Ho Jung, Woo Suck Suh, So Hyun Park, Kyoung Soon Cho, Moon Hee Lee, Mun Sung Cho, Sun Young Park, Yun Jung Choi, Seung Hoon Hahn, Byung Kyu Suh, Byung Churl Lee, Won Kyoung Cho
Publikováno v:
Annals of Pediatric Endocrinology & Metabolism. 17:106
Results: GV during the first year of GnRHa treatment was 5.9 ±1.0 cm/yr and decreased significantly to 5.4±1.1 cm/yr during the second year of treatment (P = 0.005). GV during the third year (5.0±1.0 cm/yr) was not different from GV during the sec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::054002dc3f3e6f0edd70774ab7fa636b
https://doi.org/10.6065/apem.2012.17.2.106
https://doi.org/10.6065/apem.2012.17.2.106